(Senior) Director New Product Planning

Incyte Corporation; Morges; Vor Ort; CHF 240.000 - 360.000; Vollzeit

Zusammenfassung

International Hematology & Oncology is seeking a Director, International New Product Planning to shape the commercial strategy for hematology and oncology assets across global markets. You will lead cross-functional teams and translate scientific innovation into differentiated value.

The role collaborates with Global Development, Medical Affairs, Market Access and Commercial to optimize launches, pricing and lifecycle planning for an increasingly important portfolio.

Qualifikationen

• Significant experience in New Product Planning, Commercial Strategy, Launch Excellence or related strategic commercial functions within the pharmaceutical or biotechnology industry.
• Deep expertise within Hematology, Oncology or Specialty Care.
• Strong understanding of international healthcare systems, pricing, reimbursement and commercialization.
• Experience influencing cross-functional teams in complex global organizations.
• Demonstrated ability to translate scientific innovation into commercially successful strategies.

Aufgaben

• Develop integrated commercial strategies for priority Hematology and Oncology assets across International markets.
• Shape Target Product Profiles by identifying opportunities for meaningful clinical and commercial differentiation.
• Influence development strategies through market insights, competitive intelligence and evolving treatment landscapes.
• Partner with Clinical Development to help optimize trial design, evidence generation and market relevance.
• Build strategic recommendations that strengthen portfolio prioritization and long-term asset value.
• Build robust forecasting, valuation and scenario-planning models to support strategic investment decisions.
• Define differentiated value propositions for physicians, patients, healthcare systems and payers.
• Assess market opportunities, competitive dynamics and future treatment paradigms across International markets.
• Partner with Market Access and HEOR to shape pricing, reimbursement and evidence-generation strategies.
• Identify opportunities to maximize long‑term lifecycle value across the portfolio.

Kenntnisse

New Product Planning

Commercial strategy

Launch excellence

Hematology/Oncology

Cross-functional leadership

Ausbildung

MBA or equivalent

PharmD/PhD/MD

Jobbeschreibung

Overview

Build the Future of Hematology & Oncology

International Hematology & Oncology is entering a defining chapter.

As our portfolio expands across hematologic malignancies and solid tumors, we are building the commercial platform that will establish International as a major driver of Incyte's future growth.

This is an opportunity to shape strategy years before launch, influence global decisions, and help bring transformational innovation to patients worldwide.

The work you do today will help determine the success of tomorrow's pipeline.

Why this role matters

Building a successful oncology franchise begins long before a medicine reaches patients.

It begins with the strategic decisions that shape development, define differentiation, anticipate market needs and create long-term value.

As Director, International New Product Planning, you will operate where science, strategy and commercial excellence intersect. Working across Global Development, Medical Affairs, Market Access and Commercial, you will help shape how future assets are developed, positioned and brought to markets around the world.

Beyond individual products, you will contribute to building an International organization that increasingly influences global portfolio decisions and strengthens Incyte's leadership in Hematology & Oncology.

Your Mission

Shape the commercial future of our Hematology & Oncology pipeline by transforming scientific innovation into differentiated, globally competitive medicines that create meaningful value for patients, healthcare systems and Incyte.

Where You Will Make an Impact

Shape Future Assets

The strongest launches begin years before approval.

You will influence the commercial direction of pipeline assets from the earliest stages of development, ensuring International perspectives help shape global decisions.

• Develop integrated commercial strategies for priority Hematology and Oncology assets across International markets.
• Shape Target Product Profiles by identifying opportunities for meaningful clinical and commercial differentiation.
• Influence development strategies through market insights, competitive intelligence and evolving treatment landscapes.
• Partner with Clinical Development to help optimize trial design, evidence generation and market relevance.
• Build strategic recommendations that strengthen portfolio prioritization and long-term asset value.

Transform Innovation into Commercial Opportunity

Scientific innovation creates opportunity. Commercial strategy unlocks its full potential.

• Build robust forecasting, valuation and scenario-planning models to support strategic investment decisions.
• Define differentiated value propositions for physicians, patients, healthcare systems and payers.
• Assess market opportunities, competitive dynamics and future treatment paradigms across International markets.
• Partner with Market Access and HEOR to shape pricing, reimbursement and evidence-generation strategies.
• Identify opportunities to maximize long‑term lifecycle value across the portfolio.

Influence Enterprise Strategy

International is becoming an increasingly important voice in shaping the future of our portfolio.

You will help strengthen that influence by building alignment across senior stakeholders and translating complex information into clear strategic direction.

• Represent International Commercial within cross‑functional governance and asset teams.
• Influence strategic decisions across Development, Medical Affairs, Commercial and Market Access.
• Build alignment across regional and affiliate organizations around one integrated commercial vision.
• Challenge assumptions through thoughtful analysis and forward‑looking strategic thinking.
• Contribute to portfolio decisions that strengthen International's role as a key growth engine for Incyte.

Build Winning Launch Strategies

Every successful launch builds the platform for the next generation of innovation.

• Design International go‑to‑market strategies tailored to diverse healthcare environments.
• Shape launch sequencing, commercial models and market‑entry strategies across priority countries.
• Lead cross‑functional launch planning from early preparation through commercialization.
• Drive launch readiness with clarity, discipline and a relentless focus on execution excellence.
• Capture learnings that continuously strengthen future launches across the portfolio.

What Success Looks Like

Success in this role is measured by the long‑term value you help create.

• Assets that enter development with stronger commercial differentiation.
• Commercial strategies that influence global decision‑making.
• Launches built on deep market insight and enterprise‑wide alignment.
• Faster and broader patient access across International markets.
• A stronger, more influential International Hematology & Oncology organization prepared to lead future growth.

The Mindset to Build What's Next

We are looking for someone who naturally thinks beyond today's milestones.

Someone who sees complexity as an opportunity to create clarity.

You combine scientific curiosity with commercial rigor and strategic vision. You are comfortable navigating ambiguity, influencing senior stakeholders and making decisions where science, business and patient needs intersect.

You build trusted partnerships across functions and geographies. You challenge constructively, think boldly and maintain focus on creating sustainable value over the long term.

Most importantly, you are energized by building.

Building strategies.

Building partnerships.

Building competitive advantage.

Building the future of International Hematology & Oncology.

Qualifications

Experience

• Significant experience in New Product Planning, Commercial Strategy, Launch Excellence or related strategic commercial functions within the pharmaceutical or biotechnology industry.
• Deep expertise within Hematology, Oncology or Specialty Care.
• Strong understanding of international healthcare systems, pricing, reimbursement and commercialization.
• Experience influencing cross‑functional teams in complex global organizations.
• Demonstrated ability to translate scientific innovation into commercially successful strategies.

Education

Advanced scientific or business degree required (MBA, PharmD, PhD, MD or equivalent preferred).

Why Incyte. Why Now.

International Hematology & Oncology is building far more than a portfolio.

We are building the capabilities, partnerships and commercial platform that will define the next generation of growth for Incyte.

The leaders who join us today will help shape the medicines we develop, the strategies we pursue and the impact we create for patients around the world.

This is an opportunity to help build something that will matter for years to come.

Disclaimer: The above statements are intended to describe the general nature and level of work performed by employees assigned to this job. They are not intended to be an exhaustive list of all duties, responsibilities, and qualifications. Management reserves the right to change or modify such duties as required.